STAT

MAY 4, 2023

Food and Drug Administration licensed the first-ever vaccine for respiratory syncytial virus, or RSV , completing an elusive quest that has been decades in the making , STAT writes. A vaccine that was developed by Pfizer and aimed at the same demographic is expected to be approved by the end of the month.

Vaccines 246

Vaccines Hospitals 246

STAT

JUNE 26, 2025

After making a brief visit to the hospital due to feeling lightheaded, Senate Minority Leader Chuck Schumer (D-NY) gave this sage advice : drink some water and stay out of the heat. Send me your advice for avoiding heat stroke and any health care news tips at John.Wilkerson@statnews.com or via Signal at John_Wilkerson.07.

Vaccines 136

Vaccines Hospitals 136

Pharma Times

DECEMBER 11, 2023

New data highlights the inequalities in emergency hospital rates and vaccinations - News - PharmaTimes

Vaccines 160

Vaccines Hospitals 160

NY Times

AUGUST 3, 2021

The Food and Drug Administration’s move is expected to kick off more vaccination mandates for hospital workers, college students and federal troops.

Vaccines 140

Vaccines Hospitals Immunization Immunity 140

NY Times

AUGUST 23, 2021

The move was expected to kick off a round of new vaccination mandates from hospitals, schools and private companies.

Vaccines 98

Vaccines Hospitals Immunization Immunity 98

NY Times

SEPTEMBER 17, 2021

The study found that the shots’ effectiveness in preventing hospitalization fell to 77 percent from 91 percent four months after full vaccination.

Vaccines 99

Vaccines Hospitals Immunization Immunity 99

European Pharmaceutical Review

OCTOBER 24, 2023

PENBRAYA (meningococcal groups A, B, C, W and Y vaccine), the first and only pentavalent vaccine that provides the broadest serogroup coverage of any meningococcal vaccine available in the US for meningococcal disease in individuals aged 10 to 25 years old, has been approved by the US Food and Drug Administration (FDA).

Vaccines 105

Vaccines Hospitals 105

pharmaphorum

MARCH 2, 2021

Zebra Technologies healthcare lead Chris Sullivan discusses the COVID-19 vaccine rollout and how technology can streamline the process to combat new variants. . While the rollout of the COVID-19 vaccine has signified the first signs of light at the end of the tunnel, the reality is that this public health crisis is still far from over.

Vaccines 119

Vaccines Adverse Reactions Documentation Labelling 119

Pharmacy Times

JUNE 10, 2025

Low uptake of vaccination to protect against invasive pneumococcal disease (IPD) was observed both before and after a pneumococcal-related hospitalization, with countless missed vaccination opportunities documented.

Hospitals 26

Hospitals Vaccines Documentation 26

Express Pharma

SEPTEMBER 12, 2024

Indian Immunologicals (IIL), a vaccine manufacturer, has signed a Memorandum of Agreement (MoA) with the Indian Council of Medical Research (ICMR) to develop India’s first codon de-optimized live attenuated Zika vaccine. Currently, no vaccine is available for Zika prevention.

Vaccines 105

Vaccines Hospitals 105

Express Pharma

SEPTEMBER 26, 2023

Indian Institute of Technology Mandi researchers, led by Dr Amit Prasad, Associate Professor, School of Biosciences and Bioengineering, has made strides in the development of vaccines against the pork tapeworm (T. Traditionally, tapeworm vaccines have been developed using products or antigens derived from tapeworm eggs or larvae.

Vaccines 111

Vaccines Immunity Immunization Hospitals 111

Pharmaceutical Technology

JUNE 20, 2025

The Department of Health – Abu Dhabi (DoH) and Sanofi have signed a memorandum of understanding (MoU) to bolster vaccine development by leveraging local health-tech ecosystems and research infrastructure. Credit: Department of Health Abu Dhabi. Give your business an edge with our leading industry insights.

Vaccines 52

Vaccines Pharmaceutical Manufacturing Communication Hospitals 52

pharmaphorum

DECEMBER 17, 2020

Trials of a fifth COVID-19 vaccine have begun in the UK, as IT issues threaten to delay the roll-out of the shot from Pfizer/BioNTech. France’s Valneva begun the phase 1/2 clinical study of the inactivated vaccine candidate VLA2001 in sites across the UK, supported by the National Institute for Health Research (NIHR).

Vaccines 105

Vaccines Immunity Immunization Hospitals 105

pharmaphorum

DECEMBER 9, 2020

Reviewers from the FDA have given their blessing to the Pfizer/BioNTech COVID-19 vaccine ahead of a key meeting tomorrow – but the regulator noted that there are still uncertainties about whether the shot can stop the disease from spreading. The post FDA reviewers back Pfizer/BioNTech COVID-19 vaccine ahead of panel appeared first on.

Vaccines 111

Vaccines Adverse Reactions Documentation Immunity 111

The Pharmacist

MAY 4, 2023

A ground-breaking trial of a new Zika vaccine has started, with the first participant receiving the dose at the Royal Liverpool University Hospital, in conjunction with ongoing research at the universities of Liverpool and Manchester.

Vaccines 95

Vaccines Hospitals 95

Community Pharmacy

OCTOBER 27, 2023

While COVID-19 might not be as pressing of a problem as it was during the peak of the pandemic, the virus and its many variants still pose significant health risks that require updated vaccine protection to combat. rise, which previous year’s vaccines were not designed to protect against.

Vaccines 105

Vaccines Community Pharmacies Hospitals Immunization 105

Express Pharma

JUNE 15, 2023

The current influenza vaccines only provide protection against a limited number of strains, with the strains predicted to be dominant in the upcoming season selected for inclusion in the vaccines. Ultimately one of the biggest benefits of a universal influenza vaccine is that it could help to contain a potential pandemic.”

Vaccines 98

Vaccines Immunity Immunization Hospitals 98

pharmaphorum

SEPTEMBER 7, 2020

A trial of Russia’s Sputnik V coronavirus vaccine has shown the jab produces an immune response, although the study was too small to produce conclusive findings, particularly on safety. The vaccine also produced a T-cell response within 28 days, a secondary outcome.

Immunity 107

Immunity Immunization Vaccines Hospitals 107

pharmaphorum

OCTOBER 23, 2020

Is a century-old vaccine a ‘game-changer’ for COVID-19? This is especially true in the search for effective therapies to fight COVID-19, and a vaccine. In a worst-case scenario, misplaced hype could lead to a sudden rush to buy doses of the BCG vaccine. Understanding the link between COVID-19 and the BCG vaccine.

Vaccines 110

Vaccines Immunity Immunization Hospitals 110

pharmaphorum

JANUARY 31, 2022

It is becoming increasingly important for people all over the world to understand the importance of vaccines and to have access to the vaccines they need – especially with digital innovation driving new vaccine development. Pfizer’s Josh Raysman, Saad Saeed, and Shanaya Deboo discuss vaccine awareness, access, and innovation.

Vaccines 97

Vaccines Pharmaceutical Companies Pharmaceutical Companies Drug Development 97

pharmaphorum

SEPTEMBER 24, 2020

The UK could be the first country to carry out a COVID-19 “challenge trial” where healthy volunteers are deliberately infected with coronavirus to test vaccines, according to press reports. That vaccine is top of the World Health Organization’s list of vaccines in clinical development, which shows there are 38 potential shots in human trials.

Vaccines 98

Vaccines Immunity Immunization Hospitals 98

pharmaphorum

JUNE 2, 2021

In the latest edition of What HCPs Think , CREATION.co’s Laura Marsh looks at what healthcare professionals are saying about blood clots linked to COVID-19 vaccines. This sudden increase is due to reports of rare blood clots in recipients of the COVID-19 vaccines developed by AstraZeneca and more recently Johnson & Johnson.

Vaccines 105

Vaccines Hospitals 105

pharmaphorum

JANUARY 27, 2021

A plant in Wales manufacturing the AstraZeneca COVID-19 vaccine was evacuated on the advice of the authorities today after it was sent a suspicious package. The contract covers production of 100 million doses of the AZ vaccine. Wockhardt UK in Wrexham this morning received a suspicious package.

Vaccines 98

Vaccines Packaging Hospitals 98

Express Pharma

JULY 26, 2023

Results are based on analysis of data from 278,375 adults in New Zealand who got the vaccine between April 2018 and July 2021. Most were aged 70 or older Getting vaccinated against shingles could significantly reduce the risk of suffering a stroke or heart attack from the virus, a new study has found. Most were aged 70 or older.

Vaccines 98

Vaccines Hospitals 98

pharmaphorum

DECEMBER 8, 2020

A 90-year-old woman has become the first person given a COVID-19 vaccine as part of the UK’s mass vaccination programme. Margaret Keenan was given the injection at 06:31 this morning at University Hospitals Coventry and Warwickshire NHS Trust. The post First COVID-19 vaccinations begin in UK hospitals appeared first on.

Hospitals 52

Hospitals Vaccines 52

pharmaphorum

JUNE 27, 2021

AstraZeneca and Oxford University have started dosing patients in a trial of a new version of their COVID-19 vaccine that is designed to target the beta or South African variant of the SARS-CoV-2 virus. The post AZ starts phase 2/3 trial of new-variant COVID-19 vaccine appeared first on. The beta variant – also known as B.1.351

Vaccines 101

Vaccines Hospitals 101

Pharmaceutical Technology

JUNE 25, 2025

GlobalData Healthcare June 25, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Changes to ACIP could result in regulatory uncertainty for vaccine developers and manufacturers. Malone, an early mRNA pioneer, has made unfounded claims regarding the dangers of mRNA vaccines, which have sparked significant public backlash.

Vaccines 52

Vaccines Hospitals Packaging Communication 52

Pharmacy Times

SEPTEMBER 6, 2024

RSV vaccination was 75% effective in preventing RSV-associated hospitalizations among adults aged 60 years and older.

Hospitals 48

Hospitals Vaccines 48

Pharmacy Times

NOVEMBER 13, 2024

RSV vaccination is approximately 77% to 81% effective against hospital and emergency department encounters among older adults.

Hospitals 44

Hospitals Vaccines 44

pharmaphorum

DECEMBER 30, 2020

The UK has approved AstraZeneca and Oxford University’s COVID-19 vaccine AZD1222 in another significant step forward in the fight against the pandemic, with first doses due to be administered on Monday. The #coronavirus vaccine is our way out of the pandemic – now we need to hold our nerve while we get through this together.

Vaccines 98

Vaccines Hospitals 98

Pharmacy Times

NOVEMBER 14, 2024

Increasing vaccine coverage among adults at highest risk could lessen associated hospitalizations and severe outcomes caused by RSV.

Hospitals 45

Hospitals Vaccines 45

Pharmacy Times

DECEMBER 28, 2024

Study results show that the updated BNT162b2 XBB vaccine is effective in preventing hospitalizations or emergency department visits associated with COVID-19 complications.

Hospitals 49

Hospitals Vaccines 49

Pharmacy Times

JUNE 20, 2025

Expanding use of the 15-valent pneumococcal conjugate vaccine (PCV15) or 20-valent pneumococcal conjugate vaccine (PCV20) to all United States adults aged 50 to 64 years would result in modest budget increases over a 3-year period. 1,2 A particular disease burden is present for Black Americans.

Vaccines 29

Vaccines Pharmacy Technician Immunity Immunization 29

pharmaphorum

MARCH 11, 2022

After a period where vaccine development had fallen away, suddenly it is back in the limelight. However, for those individuals working on vaccine development, the pandemic has proven to be a validation of the important work being carried out in the field. billion from its vaccine in 2021. The ‘poor relation’.

Vaccines 81

Vaccines Diabetes Hospitals 81

Express Pharma

JUNE 20, 2023

The vaccine efforts of the COVID-19 pandemic highlighted our knowledge about gaps in the immune system. Similarly, institutes that facilitate connections between local hospitals and research institutes play an essential role. However, the spotlight has shifted to unravelling the complexities of the human immune system.

Immunity 105

Immunity Immunization Vaccines Hospitals 105

Pharmacy Times

NOVEMBER 8, 2024

Though both vaccines remain effective at preventing severe illness, Moderna’s mRNA-1273.222 vaccine was found to be significantly more effective among adults with underlying medical conditions.

Vaccines 52

Vaccines Hospitals 52

Big Molecule Watch

SEPTEMBER 3, 2024

On August 22, Moderna announced that FDA approved its supplemental Biologics License Application (“sBLA”) for a new formula of their COVID-19 vaccine, SPIKEVAX®, for individuals 12 years old and above. Emergency Use Authorization (“EUA”) was also granted for the updated vaccine for individuals aged 6 months to 11 years old.

Vaccines 59

Vaccines Hospitals 59